New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Si... ( ANN ARBOR Mich. Sept. 19 /- A new...)

New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects

Date:9/19/2007

ANN ARBOR, Mich., Sept. 19 /PRNewswire/ -- A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.

"Results of the phase 1 clinical trial are important to the fields of dermatology and infectious diseases because currently approved systemic medications for onychomycosis carry serious risks of cardiac and liver toxicity," said James Baker, MD, chief science officer and founder of NanoBio Corporation in Ann Arbor, Mich. NanoBio scientists developed the lotion.

The phase 1 data for the new lotion, NB-002, will be presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting, to be held Sept. 17 -20, 2007, in Chicago.

"At present, the vast majority of people with onychomycosis are untreated as a result of concerns for the serious toxicities associated with the available oral medications," said Baker. "Our safety data, combined with early information from the ongoing phase 2 trial, indicate that NB-002 is potentially the first treatment for onychomycosis that is highly efficacious and very safe."

NanoBio Corporation is a spin-off from the University of Michigan. The company develops novel anti-infective products and mucosal vaccines to treat or prevent a wide range of infections, from cold sores and toenail fungus to influenza and hepatitis B. Its lead products are NB-001 to treat herpes labialis and NB-002 to treat onychomycosis.

NB-002 is a topical oil-in-water nanoemulsion combined with an antimicrobial agent commonly used in oral products to treat gingivitis and other conditions of the mouth and throat. The nanoemulsion undergoes a high- energy process to shrink or "nano-size" the particles so they are small enough to enter the skin through pores and hair follicles but
'/>"/>

SOURCE NanoBio Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839
2. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
3. Apollo develops needle-free topical vaccine
4. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
5. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
6. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
9. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
10. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

Post Your Comments:

(Date:5/23/2013)... 23, 2013 MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...

(Date:5/23/2013)... 2013 BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...

(Date:5/23/2013)... TOKIO , 22. Mai 2013 ... Weiteren Ranbaxy), eine Tochtergesellschaft von Daiichi ... Sankyo), gab am 22. Mai die ... letzten Jahren ergriffen hat, um sich ... ( http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). ...

Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2 MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3 Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2

[0] MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy [0] BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress [0] Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an

... 2011 Reportlinker.com announces that ... is available in its catalogue: ... Acid Testing Market--New Product Development ... For Instrument and Reagent Suppliers ...

... NEW YORK, June 20, 2011 Reportlinker.com ... is available in its catalogue: ... 2011 http://www.reportlinker.com/p0558499/Top-Medical-Devices-and-Imaging-Technologies-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices ... medical device and imaging technologies that have ...

Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers Reportlinker Adds Top Medical Devices and Imaging Technologies 2011

(Date:5/23/2013)... (PRWEB) May 23, 2013 NDI ... funds and develops innovative neurodevice technologies, has launched ... (DBI). DBI will commercialize its groundbreaking technology ... (DBS) therapy for patients with Parkinson’s disease. ... Parkinson’s disease and generates more than $275 million ...

(Date:5/23/2013)... little was scientifically known about the human potential to ... people who are suffering in a way that motivates ... at the Center for Investigating Healthy Minds at the ... adults can be trained to be more compassionate. The ... Science , is the first to investigate whether training ...

(Date:5/23/2013)... connections in the brains of people affected by ... Peter Williamson, from Western University, to gain a ... important diseases. Dr. Williamson and colleagues have ... are disrupted in different psychiatric diseases. These ... Meeting, the annual meeting of the Canadian Association ...

(Date:5/23/2013)... DRE, Inc. is now offering the DRE ... upgrade older model DRE or BFW halogen headlights to ... , DRE and BFW customers can easily and affordably ... to LED with DRE’s American-made Xavier-C3 LED headlight conversion ... a bright, clean and even field of illumination with ...

(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... to announce the launch of Current Digital, a ... web development and digital marketing needs. Companies now ... a strategic business necessity. This can often leave ... creative strategy on preselected software platforms that they ...

Breaking Medicine News(10 mins):Health News:NDI Launches Deep Brain Innovations, LLC 2 Health News:NDI Launches Deep Brain Innovations, LLC 3 Health News:Study shows people can be trained to be more compassionate 2 Health News:Study shows people can be trained to be more compassionate 3 Health News:Study shows people can be trained to be more compassionate 4 Health News:Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease 2 Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2 Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3 Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 2 Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 3

[0] NDI Launches Deep Brain Innovations, LLC [0] Study shows people can be trained to be more compassionate [0] Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease [0] New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems [0] Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies

... in French . ,OTTAWA (June ... Health, announced today that the Government of Canada is ... principal medical isotope affected by the current shutdown at ... isotopes in combination with imaging technologies to diagnose and ...

... Extending health insurance coverage to all children in the ... benefits that are greater than the costs, according to ... Public Policy. "Providing health insurance to all children ... Ho, chair in health economics at the Baker Institute ...

... Association for Molecular Pathology (AMP) today released the text ... Federal Coordinating Council for Comparative Effectiveness Research (CER) in ... on which to focus CER activities. "CER is ... makers who see it as a method to examine ...

... season will soon arrive in the Asian territories and culicine ... the virus that causes Japanese Encephalitis (JE), which kills 10-15,000 ... the largest provider of travel medical services in the U.S. ... FDA, and is ready for distribution in the United States. ...

... (Nasdaq: BMRN ) announced today that the temporary ... is not expected to have any impact on Aldurazyme supply ... fill at the Allston Landing facility was in September 2008. ... vialed inventory on hand, utilizes a second fill finish supplier ...

... CRYSTAL, Minn., June 16 On June 4, 2009, Herzing University ... to begin a Bachelor of Science in Nursing ... of preparation. , , A new medical lab, extensive ... few of the additions brought to campus to prepare for the ...

Cached Medicine News:Health News:Providing health insurance for US children would be cheaper than expected, study says 2 Health News:AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 2 Health News:AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 3 Health News:Monsoon Season will Bring Japanese Encephalitis 2 Health News:Temporary Production Interruption at Allston Landing Manufacturing Facility Has No Impact on Aldurazyme 2 Health News:Herzing University, Minneapolis Receives Board of Nursing Approval 2

Government of Canada supports research to help address medical isotope shortage Providing health insurance for US children would be cheaper than expected, study says AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research Monsoon Season will Bring Japanese Encephalitis Temporary Production Interruption at Allston Landing Manufacturing Facility Has No Impact on Aldurazyme Herzing University, Minneapolis Receives Board of Nursing Approval

At 14 cm point, ruler is bent at 90 degrees angle brought to a blunt point at 15 cm....

Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...

Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...

Medicine Products:

Webster Ruler Colorado Needle Sinuscope. A4.0AE70 Sinuscope. A1.8AE70